isomethyleugenol has been researched along with Choroid Plexus Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergmann, M; Beschorner, R; Bewerunge-Hudler, M; Capper, D; Felsberg, J; Grundy, RG; Hartung, S; Hasselblatt, M; Hauser, P; Hovestadt, V; Jeibmann, A; Jones, DT; Keyvani, K; Kordes, U; Korshunov, A; Mittelbronn, M; Monoranu, CM; Olar, A; Paulus, W; Pfister, SM; Pietsch, T; Ruland, V; Sill, M; Thomas, C; Varlet, P; von Deimling, A; Witten, A; Wolff, JE | 1 |
1 other study(ies) available for isomethyleugenol and Choroid Plexus Neoplasms
| Article | Year |
|---|---|
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroups.
Topics: Adolescent; Carcinoma; Child; Child, Preschool; Choroid Plexus Neoplasms; Disease-Free Survival; Female; Humans; Infant; Male; Methylation; Papilloma, Choroid Plexus; Prognosis; Risk Assessment | 2016 |